---
figid: PMC6557987__fcvm-06-00069-g0002
figlink: /pmc/articles/PMC6557987/figure/F2/
number: F2
caption: Exercise-induced myokines mediate organ cross-talk and improve cardiometabolic
  health. (A) The myokine IL-6 inhibits TNF-α (), reducing inflammation and protecting
  against the formation of atherosclerosis (); stimulates GLP-1 secretion causing
  improved insulin secretion (); increases lipolysis and fatty acid oxidation in adipose
  tissue () and increases glucose uptake through the AMPK signaling pathway (, ).
  (B) Fstl1 decreases ischemic injury size through activation of the Akt/AMPK pathway
  (activating eNOS and enhancing revascularization) (, ) and early fibroblast stimulation
  (which aids in repair after ischemia-reperfusion) (). (C) Myonectin (MyoN) increases
  fatty acid uptake in adipocytes and hepatocytes (), and promotes protects against
  ischemic injury in the heart, possibly through Akt activation (). (D) NDNF improves
  survival after myocardial infarction (MI) by reducing apoptosis () through stimulation
  of the Akt/AMPK/eNOS pathway (enhancing revascularization) ().
pmcid: PMC6557987
papertitle: Effects of Exercise to Improve Cardiovascular Health.
reftext: Kelsey Pinckard, et al. Front Cardiovasc Med. 2019;6:69.
pmc_ranked_result_index: '109719'
pathway_score: 0.8580827
filename: fcvm-06-00069-g0002.jpg
figtitle: Exercise-induced myokines mediate organ cross-talk and improve cardiometabolic
  health
year: '2019'
organisms: Homo sapiens
ndex: e8f15044-df14-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6557987__fcvm-06-00069-g0002.html
  '@type': Dataset
  description: Exercise-induced myokines mediate organ cross-talk and improve cardiometabolic
    health. (A) The myokine IL-6 inhibits TNF-α (), reducing inflammation and protecting
    against the formation of atherosclerosis (); stimulates GLP-1 secretion causing
    improved insulin secretion (); increases lipolysis and fatty acid oxidation in
    adipose tissue () and increases glucose uptake through the AMPK signaling pathway
    (, ). (B) Fstl1 decreases ischemic injury size through activation of the Akt/AMPK
    pathway (activating eNOS and enhancing revascularization) (, ) and early fibroblast
    stimulation (which aids in repair after ischemia-reperfusion) (). (C) Myonectin
    (MyoN) increases fatty acid uptake in adipocytes and hepatocytes (), and promotes
    protects against ischemic injury in the heart, possibly through Akt activation
    (). (D) NDNF improves survival after myocardial infarction (MI) by reducing apoptosis
    () through stimulation of the Akt/AMPK/eNOS pathway (enhancing revascularization)
    ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT2
  - NOS3
  - PRKAB1
  - PRKAG2
  - PRKAG3
  - PRKAA2
  - AKT3
  - PRKAB2
  - PRKAG1
  - PRKAA1
  - NDNF
  - FSTL1
  - IL6
  - AKT1
  - glucose
  - Fatty acid
  - atheroscierosis
  - hchemic injury
  - ischemic injury
genes:
- word: AKT/AMPK
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AKT/AMPK
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: AKT/AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: NDNF
  symbol: NDNF
  source: hgnc_symbol
  hgnc_symbol: NDNF
  entrez: '79625'
- word: FSTL1
  symbol: FSTL1
  source: hgnc_symbol
  hgnc_symbol: FSTL1
  entrez: '11167'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: AKT/AMPK
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
chemicals:
- word: glucose
  source: MESH
  identifier: D005947
- word: Fatty acid
  source: MESH
  identifier: D005227
diseases:
- word: atheroscierosis
  source: ''
  identifier: ''
- word: hchemic injury
  source: MESH
  identifier: D058186
- word: ischemic injury
  source: MESH
  identifier: D003324
figid_alias: PMC6557987__F2
redirect_from: /figures/PMC6557987__F2
figtype: Figure
---
